Texas Instruments Inc. (TI) introduced a high-efficiency, ultra-low power step-down converter for energy harvesting and low-power applications.
Mitsubishi plans to invest 15 billion yen (US$175 million) in MOCVD systems for high brightness LED production, according to an article in the Nikkei newspaper.
Tamar Technology received orders from two major semiconductor equipment manufacturers for its Through-Silicon Via (TSV) measurement technology.
Agios Pharmaceuticals Inc., a Cambridge biotech focused on cancer metabolism-based therapeutics, has named Novartis veteran Scott Biller as chief scientific officer.
Holy Redeemer Partners with MobileMD to Deliver Health Information Exchange Services to Care CommunitySeptember 21, 2010 11:34 am | by Bio-Medicine.Org | News | Comments
WARMINSTER and HUNTINGDON VALLEY, Pa., Sept. 21 /- MobileMD, Warminster, and Holy Redeemer Health System, Huntingdon Valley, announced today an agreement to provide state-of-the-art Health Information Exchange (HIE) services to Holy Redeemer and its entire healthcare provider community....
Introduction of New Products and Increased Uptake of Innovative Materials to Drive US Bone Graft Substitute Market to Nearly $2.3 Billion by 2015September 21, 2010 11:34 am | by Bio-Medicine.Org | News | Comments
TORONTO, Sept. 21 /- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the introduction and adoption of new growth factors, combined with greater variety and improved features of newer products, will drive the US bone graft...
STOCKHOLM, Sept. 21 /- More than one in three diabetes patients skip doses or fail to take their insulin as prescribed, stating that they have done so on average three times in the last month, and 77 percent of physicians estimate that in reality this number could be as high as six...
ImmunoGen Inc. has begun clinical testing of its drug candidate SAR566658, co-developed with Paris pharmaceutical giant Sanofi-aventis, in treating ovarian, breast, cervical, lung and pancreatic cancers.
DENVER — The American Association for Cancer Research will host its Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development from Sept. 27-30, 2010, at the Sheraton Denver Downtown in Denver, Colo.
Design engineers can sometimes get so caught up with the technical specifications of a molding project that they overlook the non-technical processes and miss out on an opportunity to improve production throughput. This article lays out four tips that the design engineer should follow when taking part in their next molding project so as to get the most out of the project.
Dividends or distributions were declared or updated on the followed listed issues on the Toronto Stock Exchange on September 21, 2010.Claymore Canadian Fundamental Index Etf Units (TSX:CRQ): $0.06. Payable Jul 07. Record Jun 29.Claymore Bric Etf Units (TSX:CBQ): $0.035. Payable Jul 07. Record...
BOSTON, Sept. 21 /- Solos Endoscopy, Inc. (Pink Sheets: SNDY ) is pleased to announce that the Company will be holding its annual shareholder meeting on Tuesday, September 28, 2010 at 9:00am EDT. The meeting will be held at the Hilton of Boston/Dedham located at 25 Allied Drive, Dedham,...
A growing number of medical device disposable products are looking more like traditional sophisticated reusable instruments. There are a number of trends, both technical and non-technical, that are driving this prevailing change. This article looks to briefly discuss some of those trends and their influence on the emergence of smarter, more functional disposables.
Ensuring proper connection of leads into implantable cardiac devices can be challenging, especially for small start-ups whose specialty may not focus on this area. As a result, one company is offering a solution that can be completely integrated easily into a device to help satisfy the requirements of this component and enable a faster time to market.
Boston Scientific Corp. today announced that one of its coronary stents, the Promus Element Everolimus-Eluting Coronary Stent System, has been approved for additional treatments of diabetes and heart attacks in the European economic community.